Skip to main content

David Milstead

David Milstead
Business and investing reporter and columnist

A business journalist since 1994, David Milstead began writing for The Globe and Mail in 2009. During eight years at the Rocky Mountain News in Denver, Colo., he individually or jointly won nine national awards from SABEW, the Society of American Business Editors and Writers. He has also worked at the Wall Street Journal. An Oberlin College graduate, he passed the Level I exam in the Chartered Financial Analyst program in December 2007.

Latest articles
Canopy no longer the world’s most valuable cannabis company Subscriber content
Watchdogs to crack down on how companies report financial results Subscriber content
Getty Images/iStockphoto
U.S. shareholder presses pot firm HEXO to boost stock price or sell
Cronos, Tilray shares soar in another wild day of pot stock trading Subscriber content
Analysis
Why a short seller is winning the battle so far with Maxar Subscriber content
Analyst advises investors to buy pot stock Cronos after short-seller sparks steep sell-off Subscriber content
Potash prices are perking up, but Canada’s big fertilizer giant isn’t the best way for investors to cash in Subscriber content
Investors make big bets on Canadian auto-parts makers as possible NAFTA deal nears Subscriber content
Potash producers rallied sharply Monday. Here’s why
Stars and Dogs
The Globe’s stars and dogs for the week
Friday’s analyst upgrades and downgrades Subscriber content
Thursday’s analyst upgrades and downgrades Subscriber content
Wednesday’s analyst upgrades and downgrades Subscriber content
Tuesday’s analyst upgrades and downgrades Subscriber content
Pot stocks surge again as Canopy becomes Canada’s biggest health-sector company Subscriber content
Monday’s analyst upgrades and downgrades Subscriber content
U.S. regulators flag worries over Hydro One raising Avista rates Subscriber content
Short-seller Marc Cohodes continues campaign against Badger Daylighting
Getty Images/iStockphoto
Keep your wallet – and your sanity – intact and avoid Tesla stock Subscriber content David Milstead
Maxar Technologies dips as short-seller alleges accounting impropriety Subscriber content